Shortage of docs to deploy stents for stroke leads to a dilemma

The sudden demand for mechanical stent thrombectomy devices to treat stroke had led to a shortage of neurointerventionists to deploy the devices during the associated procedure. Some interventional cardiologists want to get involved, but many neurointerventionists don't think it's appropriate, leading to a "turf war." "I think it's something cardiologists should embrace, not because we need to take over other people's domains but because we're in the perfect position," said Dr. David Hildick-Smith, an interventional cardiologist at Royal Sussex Brighton Hospital in Brighton, U.K. But Dr. Philip Meyers, a neurointerventionalist at Columbia University Medical Center, said, "Stroke procedures really ought to be performed at comprehensive stroke centers where patients have access to the full range of stroke services, because there's so much more to the treatment of stroke than a procedure alone." More

Suggested Articles

Abbott launched a rapid coronavirus test able to deliver positive results in as little as five minutes, from a table-top box the size of a toaster.

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.

The FDA issued a wide-ranging emergency policy allowing alternative devices to be used as potentially lifesaving ventilators amid new shortages.